Traditional cancer treatments like chemotherapy and radiotherapy can induce immunogenic cell death (ICD), but their efficacy ...

COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced today it has closed a $50 million Series B ...

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also ...

A discrete helix in the fusion oncoprotein DNA binding domain shifts binding preferences toward long and dense GGAA repeats, which promotes transcriptional hub formation and drives ...

Two Danville families are betting big on ostriches as a safe alternative for Alpha-Gal Syndrome sufferers as the tick-borne illness spreads.

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...

Canadian AI lab Cohere has announced plans to acquire German AI startup Aleph Alpha. Schwarz Group — a key backer of Aleph Alpha — plans to invest $600 million in Cohere's upcoming Series E round as ...

Recent developments in generative artificial intelligence have educators from elementary to university seemingly fighting an uphill battle as they struggle to manage students’ dependence on the ...

AUSTIN, Texas, Jan. 6, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...